[1]   Effects of Two Common Promoter Polymorphisms of Transforming Growth Factor-β1 on Breast Cancer Risks in Ahvaz, West South of Iran
Iranian Journal of Cancer Prevention 2016

[2]   P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines
Cancer Letters 2016

[3]   La via del TGF-β com a diana terapèutica per inhibir la progressió tumoral i la metàstasi
2016

[4]   A Small Dibromotyrosine Derivative Purified From Pseudoceratina Sp. Suppresses TGF‐β Responsiveness by Inhibiting TGF‐β Type I Receptor Serine/Threonine …
Journal of Cellular Biochemistry 2016

[5]   Characterization of cellular and molecular responses of human glioblastoma to Transforming Growth Factor-β signalling pathway inhibition
2016

[6]   Study the effects of Dibromotyrosine Derivative in TGF-β responsiveness
2017

[7]   A Small Dibromotyrosine Derivative Purified From Pseudoceratina Sp. Suppresses TGF‐β Responsiveness by Inhibiting TGF‐β Type I Receptor Serine/Threonine …
Journal of Cellular Biochemistry 2016

[8]   Increased transforming growth factor-β and interleukin-17 transcripts in peripheral blood of breast cancer patients with different clinical stages
2018

[9]   Biemamides A–E, Inhibitors of the TGF-β Pathway That Block the Epithelial to Mesenchymal Transition
Organic Letters 2018

[10]   Determination of TGF-β pathway activity using unique combination of target genes
Patent 2018

[11]   Determination of tgf-beta pathway activity using unique combination of target genes
Patent 2016

[12]   Increased Transforming Growth Factor‑β and Interleukin‑17 Transcripts in Peripheral Blood of Breast Cancer Patients with Different Clinical Stages
2018

[13]   β-Peltoboykinolic Acid from Astilbe rubra Attenuates TGF-β1-Induced Epithelial-to-Mesenchymal Transitions in Lung Alveolar Epithelial Cells
2019